Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice

Eur J Nutr. 2016 Mar;55(2):845-854. doi: 10.1007/s00394-015-0994-y. Epub 2015 Jul 22.

Abstract

Purpose: The anti-glycative and anti-oxidative effects from Houttuynia cordata leaves aqueous extract (HCAE) in heart and kidney of diabetic mice were examined.

Methods: HCAE, at 1 or 2 %, was supplied in drinking water for 8 weeks. Plasma glucose and blood urea nitrogen (BUN) levels and creatine phosphokinase (CPK) activity were measured. The production of oxidative and inflammatory factors was determined. Activity and protein expression of associated enzymes or regulators were analyzed.

Results: HCAE intake at both doses lowered plasma glucose and BUN levels, and CPK activity and also restored creatinine clearance rate in diabetic mice. HCAE intake, only at 2 %, retained plasma insulin levels (P < 0.05). HCAE reduced reactive oxygen species, protein carbonyl, interleukin-6, tumor necrosis factor-alpha, N (ε) -(carboxymethyl)-lysine, pentosidine and fructose levels, and reserved glutathione content in heart and kidney of diabetic mice (P < 0.05). Diabetes enhanced aldose reductase (AR) activity and protein expression in heart and kidney (P < 0.05). HCAE intake at both doses decreased renal AR activity and protein expression, but only at 2 % lowered cardiac AR activity and protein expression (P < 0.05). Diabetes increased protein expression of RAGE, p47(phox) and gp91(phox), nuclear factor kappa-B (NF-κB) p50, NF-κB p65 and mitogen-activated protein kinase in heart and kidney (P < 0.05). HCAE intake only at 2 % limited RAGE expression, but at 1 and 2 % downregulated p47(phox), NF-κB p65 and p-p38 expression in these organs (P < 0.05).

Conclusions: These findings suggest that Houttuynia cordata leaves aqueous extract could ameliorate cardiac and renal injury under diabetic condition.

Keywords: Diabetes; Glycation; Houttuynia cordata; NADPH oxidase; Polyol pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / blood
  • Blood Glucose / metabolism
  • Blood Urea Nitrogen
  • Creatine Kinase / blood
  • Diabetes Mellitus, Experimental / drug therapy*
  • Dose-Response Relationship, Drug
  • Fructose / blood
  • Glutathione / blood
  • Heart / drug effects
  • Heart / physiology
  • Houttuynia / chemistry*
  • Insulin / blood
  • Interleukin-6 / blood
  • Kidney / drug effects
  • Kidney / metabolism
  • Lysine / analogs & derivatives
  • Lysine / blood
  • Male
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mitogen-Activated Protein Kinases / genetics
  • Mitogen-Activated Protein Kinases / metabolism
  • NADPH Oxidase 2
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects*
  • Plant Extracts / analysis
  • Plant Extracts / pharmacology*
  • Plant Leaves / chemistry
  • Reactive Oxygen Species / metabolism
  • Receptor for Advanced Glycation End Products / genetics
  • Receptor for Advanced Glycation End Products / metabolism
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Ager protein, mouse
  • Blood Glucose
  • Insulin
  • Interleukin-6
  • Membrane Glycoproteins
  • NF-kappa B
  • Plant Extracts
  • Reactive Oxygen Species
  • Receptor for Advanced Glycation End Products
  • Tumor Necrosis Factor-alpha
  • Fructose
  • N(6)-carboxymethyllysine
  • Arginine
  • pentosidine
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Mitogen-Activated Protein Kinases
  • Creatine Kinase
  • Glutathione
  • Lysine